Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Vanessa](/img/uploaded/aab593d7615a80d42da1c23d7d2bc16b.jpeg)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (13)
2022
-
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Thrombosis and Haemostasis, Vol. 122, Núm. 10, pp. 1625-1652
-
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 11, pp. 1844-1871
2020
-
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
European Journal of Internal Medicine, Vol. 78, pp. 63-68
2018
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
-
Quality of oral anticoagulation with Vitamin K antagonists in 'real-world' patients with atrial fibrillation: A report from the prospective multicentre FANTASIIA registry
Europace, Vol. 20, Núm. 9, pp. 1435-1441
-
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry
Thrombosis and Haemostasis, Vol. 118, Núm. 2, pp. 279-287
2017
-
Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa
Emergencias, Vol. 29, Núm. 1, pp. 18-26
-
High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study
Haemophilia, Vol. 23, Núm. 6, pp. e488-e496
2016
-
Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?
Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108
2015
-
sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation
European Journal of Clinical Investigation, Vol. 45, Núm. 9, pp. 899-905
2009
-
Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis
Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486
2008
-
Endothelial protein C receptor polymorphisms and risk of myocardial infarction
Haematologica, Vol. 93, Núm. 9, pp. 1358-1363
2007
-
Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis
Blood, Vol. 109, Núm. 10, pp. 4258-4263